ArticleMolecular cancer2024

PBA2, a novel inhibitor of the β-catenin/CBP pathway, eradicates chronic myeloid leukemia including BCR-ABL T315I mutation.

Ke Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.